NO179675C - Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse - Google Patents

Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse

Info

Publication number
NO179675C
NO179675C NO923794A NO923794A NO179675C NO 179675 C NO179675 C NO 179675C NO 923794 A NO923794 A NO 923794A NO 923794 A NO923794 A NO 923794A NO 179675 C NO179675 C NO 179675C
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
pyrimidine nucleoside
nucleoside derivatives
group
Prior art date
Application number
NO923794A
Other languages
English (en)
Norwegian (no)
Other versions
NO179675B (no
NO923794L (no
NO923794D0 (no
Inventor
Masakatsu Kaneko
Hitoshi Hotoda
Tomoyuki Shibata
Tomowo Kobayashi
Yoshihiro Mitsuhashi
Akira Matsuda
Takuma Sasaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO923794D0 publication Critical patent/NO923794D0/no
Publication of NO923794L publication Critical patent/NO923794L/no
Publication of NO179675B publication Critical patent/NO179675B/no
Publication of NO179675C publication Critical patent/NO179675C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO923794A 1991-09-30 1992-09-30 Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse NO179675C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25201591 1991-09-30

Publications (4)

Publication Number Publication Date
NO923794D0 NO923794D0 (no) 1992-09-30
NO923794L NO923794L (no) 1993-03-31
NO179675B NO179675B (no) 1996-08-19
NO179675C true NO179675C (no) 1996-11-27

Family

ID=17231394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923794A NO179675C (no) 1991-09-30 1992-09-30 Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse

Country Status (24)

Country Link
US (1) US5691319A (de)
EP (1) EP0536936B1 (de)
JP (1) JP2569251B2 (de)
KR (1) KR100255491B1 (de)
CN (1) CN1033227C (de)
AT (1) ATE141281T1 (de)
AU (1) AU654212B2 (de)
BR (1) BR1100621A (de)
CA (1) CA2079413C (de)
CZ (1) CZ289477B6 (de)
DE (1) DE69212759T2 (de)
DK (1) DK0536936T3 (de)
ES (1) ES2093211T3 (de)
FI (1) FI105556B (de)
GR (1) GR3020893T3 (de)
HK (1) HK204296A (de)
HU (2) HU221812B1 (de)
IL (1) IL103301A (de)
MX (1) MXPA92005623A (de)
NO (1) NO179675C (de)
NZ (1) NZ244574A (de)
RU (1) RU2085557C1 (de)
TW (1) TW205042B (de)
ZA (1) ZA927474B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
GB9515279D0 (en) * 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
PL186888B1 (pl) * 1997-01-24 2004-03-31 Conpharma As Pochodne gemcytabiny
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
AU4430200A (en) * 1999-05-11 2000-11-21 Sankyo Company Limited Liposome preparation of fat-soluble antitumor drug
JP3748536B2 (ja) * 2001-02-09 2006-02-22 三共株式会社 ピリミジンヌクレオシド誘導体の結晶
US6908906B2 (en) 2001-02-09 2005-06-21 Sankyo Company, Limited Crystalline forms of pyrimidine nucleoside derivative
US20050014716A1 (en) * 2003-05-21 2005-01-20 Wang Jin Wei Pancreatic cancer treatment
GB0328180D0 (en) * 2003-12-04 2004-01-07 Cyclacel Ltd Combination
MY142304A (en) 2005-01-31 2010-11-15 Taiho Pharmaceutical Co Ltd Novel pyrimidine nucleoside compound or salt thereof
GB0523041D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
EP2045256A4 (de) * 2006-07-21 2009-09-02 Taiho Pharmaceutical Co Ltd 2'-cyanopyrimidinnukleosidverbindung
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB2459779A (en) * 2008-05-08 2009-11-11 Cyclacel Ltd Process for the preparation of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine
GB0808359D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
US8530445B2 (en) 2008-06-09 2013-09-10 Cyclacel Limited Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
ES2426025T3 (es) * 2009-05-15 2013-10-18 Delta-Fly Pharma, Inc. Nuevo cristal estable de monoclorhidrato 1-(2'-ciano-2'-desoxi-beta-D-arabinofuranosil)citosina
HUE046177T2 (hu) 2011-04-14 2020-02-28 Cyclacel Ltd Szapacitabin és decitabin kombinációjának adagolási rendje akut mieloid leukémia kezelésére
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
AP2014007796A0 (en) 2011-12-22 2014-07-31 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
AU2013241341B2 (en) * 2012-03-28 2016-09-08 Fujifilm Corporation Salt of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine
WO2013171473A1 (en) 2012-05-15 2013-11-21 Cyclacel Limited Dosage regimen for sapacitabine and seliciclib
EP3236972B1 (de) * 2014-12-26 2021-07-28 Emory University Antivirale n4-hydroxycytidin derivate
CN108431017B (zh) 2015-12-03 2021-12-21 拜欧赛特有限公司 用于癌症疗法的缀合物的盐
CN108289905A (zh) 2015-12-03 2018-07-17 拜欧赛特有限公司 用于癌症疗法的阿糖胞苷缀合物
WO2019081951A1 (en) 2017-10-27 2019-05-02 Cyclacel Limited DOSAGE REGIME
CA3082191C (en) 2017-12-07 2021-09-21 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法
WO2021079129A1 (en) 2019-10-24 2021-04-29 Cyclacel Limited Dosing regimen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
EP0151189B1 (de) * 1983-07-20 1990-01-31 Teijin Limited Antineoplastisches mittel
US4818750A (en) * 1985-09-17 1989-04-04 Burroughs Wellcome Co. Treatment of human viral infections
ZA886890B (en) * 1987-10-09 1989-05-30 Hoffmann La Roche Novel dideoxycytidine derivatives
FR2640267B2 (fr) * 1988-01-19 1992-02-14 Univ Paris Curie Procede de synthese de l'azido-3(prime)-desoxy-3(prime)-thymidine et analogues
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
FR2632442B1 (fr) * 1988-06-06 1990-09-14 Framatome Sa Dispositif de mesure de parametres dans le coeur d'un reacteur nucleaire en service
JPH02104586A (ja) * 1988-06-21 1990-04-17 Moses Nam Fong Lee ピリミジン誘導体及びその使用
FR2635778A1 (fr) * 1988-08-26 1990-03-02 Ire Celltarg Sa Nouveaux derives de la 3(prime) azido-3(prime) deoxythymidine (azt) actifs contre le virus hiv du sida
JPH0678338B2 (ja) * 1988-09-09 1994-10-05 帝人株式会社 ２′，３′−ジデオキシシチジン−２′−エン誘導体、その製造方法及びそれを有効成分とする抗レトロウイルス剤
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体

Also Published As

Publication number Publication date
HU211851A9 (en) 1995-12-28
MXPA92005623A (es) 2002-06-19
FI924381A0 (fi) 1992-09-29
ES2093211T3 (es) 1996-12-16
KR100255491B1 (ko) 2000-05-01
GR3020893T3 (en) 1996-11-30
IL103301A0 (en) 1993-02-21
HK204296A (en) 1996-11-15
DK0536936T3 (da) 1997-01-13
EP0536936A1 (de) 1993-04-14
FI924381A (fi) 1993-03-31
JPH05194497A (ja) 1993-08-03
CA2079413C (en) 2003-09-09
AU2602692A (en) 1993-04-01
NO179675B (no) 1996-08-19
CN1033227C (zh) 1996-11-06
HU9203115D0 (en) 1992-12-28
HUT62310A (en) 1993-04-28
DE69212759D1 (de) 1996-09-19
HU221812B1 (hu) 2003-01-28
CA2079413A1 (en) 1993-03-31
NO923794L (no) 1993-03-31
RU2085557C1 (ru) 1997-07-27
JP2569251B2 (ja) 1997-01-08
EP0536936B1 (de) 1996-08-14
CZ298592A3 (en) 1993-12-15
NO923794D0 (no) 1992-09-30
ZA927474B (en) 1993-07-14
US5691319A (en) 1997-11-25
CN1072686A (zh) 1993-06-02
ATE141281T1 (de) 1996-08-15
DE69212759T2 (de) 1997-04-03
CZ289477B6 (cs) 2002-01-16
IL103301A (en) 1997-07-13
FI105556B (fi) 2000-09-15
TW205042B (de) 1993-05-01
NZ244574A (en) 1994-01-26
BR1100621A (pt) 1999-12-07
KR930006045A (ko) 1993-04-20
AU654212B2 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
NO179675C (no) Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse
NO992549D0 (no) Sukkerforbindelse, geleringsmiddel og fremgangsmÕte for fremstilling derav
SE8804609D0 (sv) Adenosine derivatives
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
UA27220C2 (uk) Спосіб одержання похідних 1-фенілімідазолін-2,5-діону
EP0191496A3 (en) Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component
DK0609289T3 (da) Imidazolderivater og farmaceutiske præparater med indhold deraf
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
TW259785B (en) Chemical compounds
EP0598910A4 (de) Verfahren zur herstellung von nukleosidderivaten.
AU590793B2 (en) Phenoxy pthalide derivatives
EP1069126A4 (de) Triazolpurin-derivate, medizinische zusammensetzungen die diese enthalten, den adenosin a3 rezeptor kompatibilisierendes mittel und asthma-medikament
DK480389A (da) Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet
CA2244662A1 (en) Antifungal agents
ATE189813T1 (de) Prostaglandin-i-analoga
IL95929A0 (en) Inosine/guanosine derivatives and compositions containing them
MY104164A (en) Heterocyclic compounds.
TH17780A (de)

Legal Events

Date Code Title Description
MK1K Patent expired